0.29
-3.33%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About EZZ Life Science Holdings
Its shares trade on ASX under the ticker EZZ.AX. It has been listed since 3 March 2021. In the fiscal year to 30 June 2025, it reported revenue of A$66.9m and net income of A$6.7m. At that date it held total assets of A$34.0m and shareholders' equity of A$28.1m.
EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The firm is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 3 Mar 2021
- Website
- ezzlife.com.au ↗
Leadership
Pay as last reported
- Mr. Glenn CrossNon-Executive Chairman of the Board
- Mr. Brent GoldmanChief Financial OfficerA$22,612
- Mr. Qizhou QinChief Operating Officer, Executive DirectorA$131,400
- Ms. Natalie ClimoCompany Secretary
- Mr. Ivan OshryNon-Executive DirectorA$27,818
- Ms. Hao HuangIndependent Non-Executive DirectorA$28,282
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- EZZ Life Science Holdings Ltd. distributes EAORON skincare products in Australia and New Zealand to pharmacies and supermarkets.
- EZZ Life Science Holdings Ltd. develops EZZ Hair Growth Spray and EZZ Hair Scrub for the hair care market segment.
- EZZ Life Science Holdings Ltd. focuses on genomics and precision nutrition for HPV and weight management challenges.
Weaknesses
- EZZ Life Science Holdings Ltd. has no international presence beyond Australia and New Zealand for EAORON skincare products.
- EZZ Life Science Holdings Ltd. relies on domestic and international distribution for EZZ supplements without global expansion.
- EZZ Life Science Holdings Ltd. lacks product diversity in the EZZ brand beyond hair and health supplements.
Opportunities
- EZZ Life Science Holdings Ltd. can expand EZZ supplements into the global market for vitamin and dietary supplements.
- EZZ Life Science Holdings Ltd. can leverage genomics research for new health challenges in the Life Sciences Tools & Services sector.
- EZZ Life Science Holdings Ltd. can target pediatric consumer health products with EZZ Iron Jelly and EZZ Biotic Engastro Capsule.
Threats
- EZZ Life Science Holdings Ltd. faces competition from other skincare brands in the Australian and New Zealand markets.
- EZZ Life Science Holdings Ltd. must navigate regulatory challenges in the Health Care sector for new products.
- EZZ Life Science Holdings Ltd. risks market saturation in the vitamin and dietary supplement segment.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.